Santiago, Chile

Sebastian Belmar

This inventor holds 5 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Praxis Biotech LLC, Altos Labs, Inc., Black Belt Tx Ltd. Active years: 2020-2026.

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sebastian Belmar

Introduction

Sebastian Belmar is a prominent inventor based in Santiago, Chile, known for his significant contributions to the field of biotechnology. With a total of four patents to his name, he has made strides in developing therapeutic agents that target critical biological processes.

Latest Patents

Belmar's latest patents include innovative compounds that serve as inhibitors of Activating Transcription Factor 6 (ATF6). These compounds have potential applications as therapeutic agents for treating diseases mediated by ATF6, particularly in the context of viral infections, neurodegenerative diseases, vascular diseases, and cancer. Additionally, he has developed compounds and compositions for modulating fibroblast activation protein (FAP), which may be useful in treating hyperproliferative diseases.

Career Highlights

Throughout his career, Belmar has worked with notable companies such as Praxis Biotech LLC and Altos Labs, Inc. His work in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapies.

Collaborations

Belmar has collaborated with esteemed colleagues, including Brahmam Pujala and Sebastian Bernales. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapeutic solutions.

Conclusion

Sebastian Belmar's work exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations highlight his commitment to

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…